Literature DB >> 25541495

The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?

Shen-Miao Yang1, Jian-Yong Li2, Robert Peter Gale3, Xiao-Jun Huang4.   

Abstract

Chronic lymphocytic leukemia/small lymphocytic lymphoma is common in persons of predominately European descent but rare in Asians. Why is unknown but is likely genetically-determined. Environmental factors may also operate but are likely to be less important. When CLL occurs in Asians it has different features than CLL in persons of predominately European descent. The reason(s) for this is also not understood. We reviewed data on CLL in Asians (mostly Han Chinese but also other ethnic groups) and compared these data with those from persons of predominately European descent with CLL. CLL incidence was about 5-10-fold less in Asians. Asians with CLL are younger, have atypical morphologic and immunologic features, an increased proportion of IGHV mutations and rearrangements and briefer freedom-from-progression than persons of predominately European descent with CLL. These observations provide clues to the etiology and biology of CLL. But the mystery continues; more research is needed.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Asians; CLL; Chronic lymphocytic leukemia; IGHV; Small lymphocytic lymphoma

Mesh:

Substances:

Year:  2014        PMID: 25541495     DOI: 10.1016/j.blre.2014.12.001

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  25 in total

Review 1.  The molecular pathogenesis of chronic lymphocytic leukaemia.

Authors:  Giulia Fabbri; Riccardo Dalla-Favera
Journal:  Nat Rev Cancer       Date:  2016-03       Impact factor: 60.716

2.  Ethnic and geographic diversity of chronic lymphocytic leukaemia.

Authors:  Shenmiao Yang; Abraham M Varghese; Nitin Sood; Carlos Chiattone; Norah O Akinola; Xiaojun Huang; Robert Peter Gale
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

3.  High frequency of chronic lymphocytic leukemia-like low-count monoclonal B-cell lymphocytosis in Japanese descendants living in Brazil.

Authors:  Mariane de Faria-Moss; Mihoko Yamamoto; Celso Arrais-Rodrigues; Ignacio Criado; Caio Perez Gomes; Maria de Lourdes Chauffaille; Matheus Vescovi Gonçalves; Eliza Kimura; Efstathios Koulieris; Fabio Borges; Guilhermo Dighiero; Joao Bosco Pesquero; Julia Almeida; Alberto Orfao
Journal:  Haematologica       Date:  2019-11-14       Impact factor: 9.941

4.  IGH Translocations in Chinese Patients With Chronic Lymphocytic Leukemia: Clinicopathologic Characteristics and Genetic Profile.

Authors:  Qinlu Li; Shugang Xing; Heng Zhang; Xiao Mao; Min Xiao; Ying Wang
Journal:  Front Oncol       Date:  2022-06-02       Impact factor: 5.738

5.  Bendamustine versus chlorambucil in treatment of chronic lymphocytic leukaemia in China: a randomized, open-label, parallel-controlled, phase III clinical trial.

Authors:  Daobin Zhou; Wei Xu; Hongbing Ma; Chunting Zhao; Yu Hu; Yaozhong Zhao; Depei Wu; Xielan Zhao; Yanjuan He; Jinsong Yan; Chunsen Wang; Fanyi Meng; Jie Jin; Xiaohong Zhang; Kang Yu; Jianda Hu; Yue Lv
Journal:  Invest New Drugs       Date:  2022-01-15       Impact factor: 3.651

6.  A Cross Sectional Study on T Cells and Subsets in Chronic Lymphocytic Leukemia and their Association with Clinical Phenotype.

Authors:  Mili Jain; Anushree Rai; Rashmi Kushwaha; Geeta Yadav; Sanjay Mishra; Shailendra Prasad Verma; Uma Shankar Singh; Anil Kumar Tripathi; Ashutosh Kumar
Journal:  Indian J Hematol Blood Transfus       Date:  2021-01-21       Impact factor: 0.915

7.  Clinicopathological features and outcome of chronic lymphocytic leukaemia in Chinese patients.

Authors:  Thomas Sau-Yan Chan; Yuh-Shan Lee; Ilaria Del Giudice; Marilisa Marinelli; Caterina Ilari; Luciana Cafforio; Anna Guarini; Daryl Tan; Colin Phipps; Yeow-Tee Goh; William Hwang; Allan Zhi-Kai Goh; Lisa Lai-Ping Siu; Saliangi Wu; Chun-Yin Ha; Shek-Ying Lin; Chi-Hang Kwok; Chi-Kuen Lau; Kit-Fai Wong; Robin Foà; Yok-Lam Kwong; Eric Tse
Journal:  Oncotarget       Date:  2017-04-11

8.  Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study.

Authors:  Xiaojun Huang; Lugui Qiu; Jie Jin; Daobin Zhou; Xiequn Chen; Ming Hou; Jianda Hu; Yu Hu; Xiaoyan Ke; Junmin Li; Yingmin Liang; Ting Liu; Yue Lv; Hanyun Ren; Aining Sun; Jianmin Wang; Chunting Zhao; Mariya Salman; Steven Sun; Angela Howes; Jingzhao Wang; Peng Wu; Jianyong Li
Journal:  Cancer Med       Date:  2018-03-13       Impact factor: 4.452

9.  Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH.

Authors:  Elie El Rassy; Alain Chebly; Rima Korban; Warde Semaan; Ziad Bakouny; Tarek Assi; Hampig Raphael Kourie; Fadi El Karak; Eliane Chouery; Joseph Kattan
Journal:  Int J Hematol Oncol       Date:  2017-12-21

10.  A new score including CD43 and CD180: Increased diagnostic value for atypical chronic lymphocytic leukemia.

Authors:  Yi Li; Xiwen Tong; Lifang Huang; Li Li; Chunyan Wang; Cheng He; Songya Liu; Zhiqiong Wang; Min Xiao; Xia Mao; Donghua Zhang
Journal:  Cancer Med       Date:  2021-06-01       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.